News | Latest Breaking News Stories & Headlines

AbbVie said that Botox brought in sales of $1.49 billion, ahead of combined estimates of $1.43 billion

AbbVie profit beats on better-than-expected Botox sales

AbbVie has today beaten Wall Street estimates for fourth-quarter profit today, helped by a smaller-than-expected decline in sales of its blockbuster drug, Humira, and strong demand for Botox amid stiff competition.

Business • 02 Feb 24

The Westport plant is parent Abbvie's sole manufacturing facility for the production of Botox worldwide

Allergan's Westport Botox plant makes $1.5bn in profits

Westport's status as the global production capital of Botox was further enhanced last year as world wide sales of the treatment from a local manufacturing plant increased by $1.25 billion to a record $4.88 billion (€4.43 billion).

Business • 29 Nov 23

The Westport plant is Abbvie's only Botox manufacturing facility in the world

Botox boom boosts Allergan's Westport plant

A global surge in the sales of Botox produced at Allergan's Westport plant helped the business record pre-tax profits of $1.327bn (€1.245bn) in 2021.

Business • 17 Feb 23

The US was the company's largest market accounting for 67% of all revenues

Botox maker sees surge in profits

Pre-tax profits at Botox producer, Allergan Pharmaceuticals Ireland increased by 24% to $232.5 million last year.

Business • 16 Nov 20

Abbvie said Botox cosmetic comparable sales plunged 43.1% to $226m

AbbVie reports loss as Covid-19 hits Botox sales

Drugmaker AbbVie has today reported a loss in the second quarter, as comparable sales from wrinkle treatment Botox, acquired as part of its $63 billion Allergan deal, slumped due to the impact of the Covid-19 pandemic.

Business • 31 Jul 20

Allergan recently marked the shipping of the 100 millionth vial of Botox from Westport

Allergan opens new €160m biologics plant in Westport

Allergan, the maker of Botox, is opening a new €160m biologics facility at its campus in Westport in Co Mayo.

Business • 28 Jan 20

Irish profits sagged at Botox maker Allergan last year

Pre-tax profits at Co Mayo-based Botox producer, Allergan Pharmaceuticals Ireland last year declined by 17% to $187m (€168.69m)

Business • 04 Dec 19

Allergan shareholders give AbbVie takeover green light

Shareholders at Dublin headquartered Botox-maker Allergan have strongly backed its $63bn takeover by US pharmaceutical company AbbVie.

Business • 14 Oct 19

AbbVie anounces deal to buy Botox-maker Allergan for about $63 billion

AbbVie to buy Botox-maker Allergan in $63 billion deal

AbbVie said today it would buy Botox-maker Allergan in a cash-and-stock deal for about $63 billion to add fast-growing therapeutic businesses such as medical aesthetics and eye care to its portfolio.

Business • 25 Jun 19

Allergan has received a big boost from Botox over the past several years, but investors are now looking at its pipeline for future drivers of growth

Allergan raises 2019 forecasts as Botox boosts results

Allergan today raised its profit and revenue forecasts for the year as it beat expectations for quarterly profit, fueled by higher sales of its blockbuster anti-wrinkle injection Botox.

Business • 07 May 19

The Knot says it has helped more than 40 million couples plan their weddings

163 new Connacht jobs in wedding, botox companies

A wedding planning company is to create 100 jobs in Galway, while a further 63 jobs have been announced for Mayo plant Allergan.

Connacht • 29 Apr 19

Sales of Allergan's Botox climbed 14.5% to $934.5m in the second quarter of this year

Allergan tops profit estimates on Botox sales

Allergan today topped analysts' estimates for quarterly profit and raised its forecast for annual earnings, led by stronger demand for medical aesthetic products including Botox.

Business • 26 Jul 18

Allergan said its net revenue for the first quarter rose to $3.67 billion

Botox-maker Allergan quarterly revenue rises 2.8%

Botox maker Allergan today reported a better-than-expected quarterly profit and raised its full-year forecast for adjusted net income.

Business • 30 Apr 18

Allergan said it earned $3.35 per share in the three months to the end of March

Allergan posts quarterly profit ahead of estimates

Botox-maker Allergan has reported adjusted profit that beat analysts' estimates, and raised its 2017 forecast to include its $2.48 billion acquisition of Zeltiq Aesthetics.

Business • 09 May 17

Allergan said its first quarter revenue rose to $3.80 billion from $2.56 billion

Allergan reports 48% rise in quarterly revenues

Allergan, whose $160 billion merger with Pfizer fell apart last month, today reported a better than expected quarterly profit today, led by strong sales of wrinkle treatment Botox and eye drug Restasis.

Business • 10 May 16

Actavis offer values Allergan at $219 per share

Allergan agrees to Actavis deal for $66 billion

Allergan has agreed to be bought by Actavis for $66 billion, putting an end to a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals.

Business • 17 Nov 14

New Valeant offer for Allergan values it at $49.4 billion

Valeant injects cash into bid for Botox maker

Valeant Pharmaceuticals International has raised the cash component of its unsolicited offer for Botox-maker Allergan.

Business • 28 May 14

Allergan's board of directors unanimously turned down the unsolicited offer from Valeant

Botox maker Allergan rejects takeover bid

Allergan, the US maker of Botox, has rejected a takeover bid from Valeant Pharmaceuticals, saying it "substantially undervalues" the company and questioning the Canadian firm's long-term growth plan.

Business • 12 May 14

Allergan, the maker of Botox, continues to be courted by Canada's Valeant

Ackman and Valeant team up to bid for Allergan

Activist investor William Ackman teamed up with Canada's Valeant Pharmaceuticals International to make a joint run at buying Allergan.

Business • 22 Apr 14

Botox